- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Notice of Annual General Meeting in BPC Instruments AB (publ) | 1 | Cision News | ||
| 10.04. | BPC INSTRUMENTS AB: BPC Instruments appoints new CFO | 1 | Cision News | ||
| 26.02. | BPC Instruments AB: BPC Instruments reports result for year 2024 | 409 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as an attached file to this release... ► Artikel lesen | |
| 26.02. | BPC Instruments AB: BPC Instruments reports result for year 2024 | 204 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as... ► Artikel lesen | |
| 20.02. | BPC Instruments AB: BPC Instruments receives order from DairyExperts for animal nutrition research | 365 | PR Newswire | LUND, Sweden, Feb. 20, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces an order of approx. SEK 0.5 million from DairyExperts, a US-based organisation specialising in livestock... ► Artikel lesen | |
| 12.02. | Bulletin from the Extraordinary General Meeting of BPC Instruments AB (publ) | 1 | Cision News | ||
| BPC INSTRUMENTS Aktie jetzt für 0€ handeln | |||||
| 24.01. | BPC Instruments AB: BPC announces Directed Share Issue to Eiffel Investment Group | 468 | PR Newswire | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 24.01. | Notice of Extraordinary General Meeting in BPC Instruments AB (publ) | 2 | Cision News | ||
| 08.01. | BPC INSTRUMENTS AB: BPC Instruments expands to new facility in Lund | 1 | Cision News | ||
| 08.01. | WIHLBORGS FASTIGHETER AB: New build by Wihlborgs for BPC Instruments in Lund | 5 | Cision News | ||
| 20.12.24 | BPC Instruments AB: Berenberg acquires shares in BPC | 595 | PR Newswire | LUND, Sweden, Dec. 20, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces that the Berenberg European Micro Cap Fund has acquired 4.8 percent of outstanding shares in BPC via... ► Artikel lesen | |
| 12.12.24 | BPC Instruments AB: BPC Instruments receives orders of 1,1 MSEK for newly launched BPC Air | 690 | PR Newswire | LUND, Sweden, Dec. 12, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") is pleased to announce orders from KTH Sweden and University of Texas USA, totaling 1,1 MSEK. These orders include... ► Artikel lesen | |
| 05.12.24 | BPC INSTRUMENTS AB: BPC Instruments receives orders from US bioenergy firm valued at 1.1 MSEK | 1 | Cision News | ||
| 14.11.24 | BPC Instruments AB: BPC Instruments reports results for the period January - September 2024 | 1.022 | PR Newswire | LUND, Sweden, Nov. 14, 2024 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1-September 30, 2024. The interim report is available as an attached... ► Artikel lesen | |
| 23.09.24 | BPC Instruments AB: BPC Instruments launches the BPC Titan - a new solution for gas flow and volume monitoring in pilot and small scales fermentation processes | 812 | PR Newswire | LUND, Sweden, Sept. 23, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces the global launch of its latest innovation, the BPC Titan, specifically designed for biological fermentation... ► Artikel lesen | |
| 28.08.24 | BPC Instruments AB: BPC Instruments reports results for H1 and Q2 2024 | 654 | PR Newswire | LUND, Sweden, Aug. 28, 2024 /PRNewswire/ -- BPC Instruments ("BPC" or "the Company") hereby publishes the half-year report for the period January 1-June 30, 2024. The half-year report is... ► Artikel lesen | |
| 26.08.24 | BPC Instruments AB: BPC secures additional orders from a multinational oil and gas company for biogas production | 1.300 | PR Newswire | LUND, Sweden, Aug. 26, 2024 /PRNewswire/ -- BPC Instruments AB ("BPC") is proud to announce the receipt of two consecutive purchase orders from the California-based branch of a prominent... ► Artikel lesen | |
| 17.07.24 | BPC Instruments AB: BPC secures order from Spanish Research Institute for enhanced anaerobic digestion research | 479 | PR Newswire | LUND, Sweden, July 17, 2024 /PRNewswire/ -- BPC Instruments AB ("BPC") has received a purchase order from a Spanish research institute to advance their anaerobic digestion research to meet... ► Artikel lesen | |
| 09.07.24 | BPC Instruments AB: BPC receives order for four equipment packages for continuous biogas process simulation | 651 | PR Newswire | LUND, Sweden, July 9, 2024 /PRNewswire/ -- BPC Instruments AB ("BPC") has received a purchase order for four equipment packages from a US-based firm specializing in converting food and farm... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 37,020 | -1,57 % | UBS stuft QIAGEN NV auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Qiagen bei einem Kursziel von 48 US-Dollar auf "Neutral" belassen. Die Ziele seien bestätigt worden, nähere Details seien... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 23,480 | -36,02 % | Summit Therapeutics: Überzeugende Daten - BioNTech gibt ebenfalls mächtig Gas | Die Biotech-Gesellschaft Summit Therapeutics, mit einem Börsenwert von gut 20 Milliarden Dollar kein kleines Unternehmen mehr, kann am Mittwoch erneut über vielversprechende Daten zum großen Hoffnungsträger... ► Artikel lesen | |
| ADMA BIOLOGICS | 21,860 | -2,10 % | ADMA Biologics, Inc.: ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | FY 2024 Total Revenue of $426.5 Million, a 65% YoY Increase FY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation Allowance Tax Benefit FY 2024 Adjusted EBITDA(1)... ► Artikel lesen | |
| TARSUS PHARMACEUTICALS | 50,000 | +0,06 % | Tarsus Pharmaceuticals, Inc: Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 | ||
| TEMPUS AI | 52,90 | -1,13 % | Gemeinsam gegen Krebs: Tempus AI, AstraZeneca und Pathos AI entwickeln KI-Modell | CHICAGO, Illinois (IT-Times) - Das Diagnose-Technologie-Unternehmen Tempus AI hat heute bekannt gegeben, zusammen mit AstraZeneca und Pathos AI ein Foundation-Modell im Bereich der Onkologie zu entwickeln.... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 44,740 | -0,42 % | Hohes Potenzial: Merck KGaA vor Milliarden-Deal: US-Krebsspezialist SpringWorks im Visier | © Foto: Arne Dedert/dpaDer deutsche Pharmakonzern Merck plant den Kauf eines vielversprechenden US-Wettbewerbers. Die Gelegenheit ist günstig.Der Darmstädter Pharma- und Technologiekonzern Merck KGaA... ► Artikel lesen | |
| EVOTEC | 7,382 | +0,52 % | Aktien KW 16 Erholung. Aber: Death Cross als Crash-Menetekel? Oder gibt's Hoffnung? News. Rheinmetall. Kontron. Evotec. Nvidia. Hamborner REIT. MHP Hotels. Forvia Hella. Hensoldt. Circus. Berentzen. Fortec. Carl Zeiss MediTec. Drägerwerk. Agnicio Mining | Aktien Wochenrückblick - die Märkte scheinen sich langsam an die Zitterphase zu gewöhnen. Aktuelle Kurserholung dauerhaft? Oder was kommt noch: Zollankündigung, Handelskrieg mit China, 90 Tage Moratorium... ► Artikel lesen | |
| BIONTECH | 102,10 | -0,10 % | BioNTech-Aktie: Ein schnelles Ende! | News von Trading-Treff.de BioNTech schafft es derzeit einfach nicht, die negativen Stimmungen am Markt zu besiegen. Die Aktie verlor am Donnerstag rund 1,6 %. Damit ist der Wert wieder auf dem Weg in... ► Artikel lesen | |
| DYNE THERAPEUTICS | 11,060 | -0,45 % | Dyne Therapeutics, Inc.: Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy | - Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 29,610 | +0,61 % | JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play? | ||
| VERVE THERAPEUTICS | 5,760 | -0,35 % | Why Verve Therapeutics Zoomed 40% Higher This Week | ||
| RECURSION PHARMACEUTICALS | 5,740 | -0,17 % | Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards? | ||
| VIR BIOTECHNOLOGY | 6,120 | -2,70 % | Vir Biotechnology, Inc.: Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025 | Phase 2 SOLSTICE subgroup analysis data in chronic hepatitis delta selected for poster presentation, and to be highlighted during EASL poster tour 24 Week post-treatment follow-up data... ► Artikel lesen | |
| CG ONCOLOGY | 22,400 | +4,04 % | CG Oncology Inc.: CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates | - Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) - - Initiated... ► Artikel lesen | |
| RELAY THERAPEUTICS | 3,200 | +0,31 % | Relay Therapeutics, Inc.: Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival | New interim data show 11.4-month median PFS in 2L patients with PI3Ka-mutated, HR+/HER2- metastatic breast cancer at RP2D 39% confirmed ORR across all patients & 67% in patients with kinase mutations... ► Artikel lesen |
Das Unternehmen BPC INSTRUMENTS AB kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 3,450 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BPC INSTRUMENTS AB finden Sie auf Wallstreet Online.
